Marketing-authorisation holder · Austria
Takeda Manufacturing Austria Ag
71 medicines in 6 countries, as authorisation holder and manufacturer.
Group structure
Other companies in the group
United States2
Belgium1
Canada1
11 more countries
Denmark1
Germany1
Norway1
Poland1
Saudi Arabia1
Serbia1
United Kingdom1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 71
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 27 | 27 | 0 | CompaniesAll medicines |
| Netherlands | 14 | 14 | 0 | CompaniesAll medicines |
| Saudi Arabia | 12 | 12 | 0 | CompaniesAll medicines |
| European Union (EMA) | 6 | 6 | 0 | CompaniesAll medicines |
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
| Romania | 6 | 0 | 6 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- AntihaemorrhagicsBlood and blood-forming organs · ATC B02B
- Antithrombotic agentsBlood and blood-forming organs · ATC B01A
- Immune sera and immunoglobulinsAnti-infectives for systemic use · ATC J06B
- Other haematological agentsBlood and blood-forming organs · ATC B06A
Top substances
The active substances in most of its medicines.
- Antihemophilic factor37 medicines
- Inmunoglobulina humana normal6 medicines
- Radamts4 medicines
- Aprotinin3 medicines
- Human fibrinogen3 medicines
- Human normal immunoglobulin3 medicines
- Human thrombin3 medicines
- Protein c3 medicines
- Calcium chloride3 medicines
- Adamts recombinant2 medicines
- Agua para preparaciones inyectables2 medicines
- Albumin2 medicines
- Proteina c plasma humano purificadacon anticuerpos monoclonales raton2 medicines
- Immunoglobulina umana normale2 medicines
- Factor viii inhibitor bypassing activity1 medicine
- Omfiloctocog alfa1 medicine
- C1-inhibitor, plasma derived1 medicine
- Human c1-esterase inhibitor1 medicine
- Inhibidor la c1 esterasa1 medicine
- C1-esteraseremmer1 medicine
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- takeda manufacturing austria
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
All 13 sources
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.